Latest Commercial Partnerships News

Page 8 of 22
EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.
Ada Torres
Ada Torres
18 Mar 2026
Lynas Rare Earths and Japan Australia Rare Earths B.V. have extended their supply agreement to 2038, securing firm commitments for critical rare earths with a pricing floor and upside sharing mechanism.
Maxwell Dee
Maxwell Dee
10 Mar 2026
Audeara Limited has initiated three new white-label Auracast™ programs with Clinico Inc., alongside launching its BT-03 Audio Broadcaster in Australia, marking a significant step in scaling its audio technology globally.
Sophie Babbage
Sophie Babbage
9 Mar 2026
Nimy Resources has addressed a recent spike in its share price and trading volume, attributing the movement to its Managing Director's U.S. trade mission and the release of a commissioned research article.
Maxwell Dee
Maxwell Dee
5 Mar 2026
Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.
Ada Torres
Ada Torres
2 Mar 2026
Merino & Co. Limited reported a 60.5% drop in revenue and a 28.2% increase in net loss for the half-year ending December 2025, reflecting a strategic investment phase aimed at future growth. The company is expanding production capacity and building inventory ahead of wholesale expansion, signaling a pivot towards revenue acceleration.
Victor Sage
Victor Sage
27 Feb 2026
Brisbane Broncos Limited has reported a robust 2025 financial year, with profit before tax soaring 35% to $11.34 million, buoyed by premiership wins in both the NRL and NRLW competitions. The club also declared a special dividend, reflecting its strong commercial and community momentum.
Victor Sage
Victor Sage
27 Feb 2026
Cynata Therapeutics reported a reduced half-year loss alongside progress in pivotal clinical trials, extending its cash runway into mid-2026. Investors await critical data from Phase 3 and Phase 2 studies expected in the coming months.
Ada Torres
Ada Torres
26 Feb 2026
BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.
Sophie Babbage
Sophie Babbage
26 Feb 2026
ReNerve Limited reported a half-year loss of $2.72 million, up 47% from last year, as it expands its nerve repair product portfolio and secures new regulatory approvals in Asia-Pacific.
Ada Torres
Ada Torres
26 Feb 2026
Firebird Metals has locked in exclusive global rights to five critical LMFP patents, solidifying its position in the lithium-ion battery materials market and paving the way for its Australian Demonstration Plant.
Maxwell Dee
Maxwell Dee
26 Feb 2026
Oliver’s Real Food Limited has reported a statutory net profit after tax of $995,000 for the half-year ended December 2025, marking a $1.82 million turnaround from the previous loss. This improvement comes despite a 6.5% revenue decline, driven by strategic store closures and disciplined cost management.
Victor Sage
Victor Sage
25 Feb 2026

Browse the archive

Full archive